source
- STAT+: Makers of rare disease drugs seek exemption from Trump’s price-cut pilotsA coalition of biotech firms is lobbying to exclude orphan drugs from new federal pilot programs aimed at lowering Medicare drug costs.STAT · 8d ago↗ source
- Recon: Novo sues Lilly over weight-loss drug ads; Gilead, Merck say HIV pill keeps HIV suppressed in two Phase 3 trialsWelcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 9d ago↗ source
- FDA cites companies for CGMP violations, informed consent failureThe US Food and Drug Administration has issued warning letters to several drug makers for failing to meet its current good manufacturing practices (CGMP) requirements and a company for failing to s…